Vanguard Group Inc Co Diagnostics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,781,283 shares of CODX stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,781,283
Previous 1,781,283
-0.0%
Holding current value
$2.39 Million
Previous $2.37 Million
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CODX
# of Institutions
46Shares Held
4.23MCall Options Held
22.9KPut Options Held
30.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny600KShares$804,5360.0% of portfolio
-
Black Rock Inc. New York, NY500KShares$670,0670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA294KShares$394,5250.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$365,6860.01% of portfolio
-
Kestra Advisory Services, LLC149KShares$199,5800.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $45.3M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...